Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4+ T cells of psoriasis vulgaris

Clinical Immunology

Volumn 150, Issue 1, 2014, Pages 22-30

  Zhao, Ming ^a   Wang, Li tao ^a   Liang, Gong ping ^a   Zhang, Peng ^a   Deng, Xin jie ^a   Tang, Qian ^a   Zhai, Han yue ^a   Chang, Christopher C ^b   Su, Yu wen ^a   Lu, Qian jin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

CD4+ T cells; FOXP3; MicroRNA; MiR 210; Psoriasis vulgaris; Treg cells

Indexed keywords

BETA ACTIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 23; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 193B; MICRORNA 210; MICRORNA 501; MICRORNA 584; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS VULGARIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; T LYMPHOCYTE ACTIVATION; UPREGULATION; WESTERN BLOTTING;

CD4(+) T CELLS; FOXP3; MICRORNA; MIR-210; PSORIASIS VULGARIS; TREG CELLS;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PSORIASIS; RNA, MESSENGER; UP-REGULATION; YOUNG ADULT;

EID: 84889666177     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.10.009     Document Type: Article

References (42)

1. Lowes M.A., Bowcock A.M., Krueger J.G. Pathogenesis and therapy of psoriasis. Nature 2007, 445:866-873.
2. Griffiths C.E., Barker J.N. Pathogenesis and clinical features of psoriasis. Lancet 2007, 370:263-271.
3. Bata-Csorgo Z., Hammerberg C., Voorhees J.J., Cooper K.D. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J. Invest. Dermatol. 1995, 105:89S-94S.
4. Nograles K.E., Davidovici B., Krueger J.G. New insights in the immunologic basis of psoriasis. Semin. Cutan. Med. Surg. 2010, 29:3-9.
5. + subsets. J. Invest. Dermatol. 1998, 111:1072-1078.
6. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., Enk A.H. Identification and functional characterization of human CD4(+) CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001, 193:1285-1294.
7. Levings M.K., Sangregorio R., Roncarolo M.G. Human CD25(+) CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 2001, 193:1295-1302.
8. Tai X., Van Laethem F., Pobezinsky L., Guinter T., Sharrow S.O., Adams A., et al. Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood 2012, 119:5155-5163.
9. Taylor A., Verhagen J., Blaser K., Akdis M., Akdis C.A. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology 2006, 117:433-442.
10. Coffer P.J., Burgering B.M. Forkhead-box transcription factors and their role in the immune system. Nat. Rev. Immunol. 2004, 4:889-899.
11. Marson A., Kretschmer K., Frampton G.M., Jacobsen E.S., Polansky J.K., MacIsaac K.D., et al. FOXP3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007, 445:931-935.
12. + Treg cells in psoriasis vulgaris. J. Dermatol. Sci. 2008, 51:200-203.
13. + T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. Dermatology 2009, 219:250-258.
14. + T-regulatory cells in psoriasis. Correlation between their numbers and biologics-induced clinical improvement. Eur. J. Dermatol. 2011, 21:344-348.
15. + CD25 high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. 2005, 174:164-173.
16. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
17. Meisgen F., Xu N., Wei T., Janson P.C., Obad S., Broom O., et al. miR-21 is up-regulated in psoriasis and suppresses T cell apoptosis. Exp. Dermatol. 2012, 21:312-314.
18. Xu N., Meisgen F., Butler L.M., Han G., Wang X.J., Soderberg-Naucler C., et al. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J. Immunol. 2013, 190:678-688.
19. Zibert J.R., Lovendorf M.B., Litman T., Olsen J., Kaczkowski B., Skov L. MicroRNAs and potential target interactions in psoriasis. J. Dermatol. Sci. 2010, 58:177-185.
20. + T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum. 2012, 64:2953-2963.
21. + T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum. 2011, 63:1376-1386.
22. Tomankova T., Petrek M., Gallo J., Kriegova E., Tomankova T., Petrek M., Gallo J., Kriegova E. MicroRNAs: emerging regulators of immune-mediated diseases. Scand. J. Immunol. 2011, 10.1111/j.1365-3083.2011.02650.x.
23. Singh R.P., Massachi I., Manickavel S., Singh S., Rao N.P., Hasan S., et al. The role of miRNA in inflammation and autoimmunity. Autoimmun. Rev. 2013, (pii: S1568-9972(13)00126-2). 10.1016/j.autrev.2013.07.003.
24. Ivan M., Harris A.L., Martelli F., Kulshreshtha R. Hypoxia response and microRNAs: no longer two separate worlds. J. Cell. Mol. Med. 2008, 12:1426-1431.
25. Foekens J.A., Sieuwerts A.M., Smid M., Look M.P., de Weerd V., Boersma A.W., et al. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13021-13026.
26. Greither T., Grochola L.F., Udelnow A., Lautenschlager C., Wurl P., Taubert H. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int. J. Cancer 2010, 126:73-80.
27. Gee H.E., Camps C., Buffa F.M., Patiar S., Winter S.C., Betts G., et al. Hsa-miR-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010, 116:2148-2158.
28. Hu S., Huang M., Li Z., Jia F., Ghosh Z., Lijkwan M.A., et al. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010, 122:S124-S131.
29. Qi J., Qiao Y., Wang P., Li S., Zhao W., Gao C. MicroRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-kappaB1 in murine macrophages. FEBS Lett. 2012, 586:1201-1207.
30. Quaglino P., Bergallo M., Ponti R., Barberio E., Cicchelli S., Buffa E., et al. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response. Dermatology 2011, 223:57-67.
31. Racz E., Kurek D., Kant M., Baerveldt E.M., Florencia E., Mourits S., et al. GATA3 expression is decreased in psoriasis and during epidermal regeneration; induction by narrow-band UVB and IL-4. PLoS One 2011, 6:e19806.
32. Sahoo A., Lee C.G., Jash A., Son J.S., Kim G., Kwon H.K., et al. Stat6 and c-Jun mediate Th2 cell-specific IL-24 gene expression. J. Immunol. 2011, 186:4098-4109.
33. + regulatory T cells. Nat. Immunol. 2003, 4:330-336.
34. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor FOXP3. Science 2003, 299:1057-1061.
35. Buckner J.H. Mechanisms of impaired regulation by CD4(+) CD25(+) FOXP3(+) regulatory T cells in human autoimmune diseases. Nat. Rev. Immunol. 2010, 10:849-859.
36. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat. Rev. Immunol. 2008, 8:523-532.
37. Wan Y.Y., Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated FOXP3 expression. Nature 2007, 445:766-770.
38. Ha T.Y. The role of microRNAs in regulatory T cells and in the immune response. Immune Netw. 2011, 11:11-41.
39. Lu L.F., Boldin M.P., Chaudhry A., Lin L.L., Taganov K.D., Hanada T., et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010, 142:914-929.
40. + regulatory T cells in healthy human skin and autoimmune dermatoses. Int. J. Dermatol. 2013, 10.1111/j.1365-4632.2012.05808.x.
41. Goodman W.A., Cooper K.D., McCormick T.S. Regulation generation: the suppressive functions of human regulatory T cells. Crit. Rev. Immunol. 2012, 32:65-79.
42. + regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J. Invest. Dermatol. 2011, 131:1853-1860.